Clinical Trial Update: Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5 [Phase 3]

View source ↗

Summary

In a Phase 3 study, the Symbicort combination (budesonide/formoterol) is evaluated against its individual components, budesonide and formoterol, for efficacy in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Foradil (formoterol)
• Pulmicort (budesonide)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED